December 3, 2025

SHINE’s Fusion Work Highlights Emerging Path for US Radioisotope Supply ()

SHINE is drawing renewed attention for its fusion-based isotope production as the US works to localize Mo-99 and reduce dependence on foreign reactors—an important shift for the nuclear medicine supply chain that underpins most diagnostic procedures...

April 8, 2025

SHINE and Sumitomo Partner to Expand Isotope and Fusion Tech in Asian Markets ()

SHINE Technologies, a Nucleation portfolio venture and next-generation fusion company, today announced a strategic partnership with Sumitomo Corporation of Americas (SCOA), a leading global trading and investment company. The partnership, formalized through a Memorandum of Understanding (MOU), will explore and develop pathways for SCOA to promote and distribute SHINE's innovative products and services throughout Japan and other Asian markets.

December 31, 2024

SHINE Technologies

SHINE Technologies – A Wisconsin-based developer of fusion energy, commercializing in the interim their high flux neutrons from DT fusion for radiation effects testing, isotope production and waste separation enroute to development of cost-effective fusion energy, producing Ilumira, a potent cancer therapy, made from Lutetium-177.

November 30, 2023

Kirk Dorius: IP Expert and CEO & General Counsel of Atom Mines

Kirk Dorius has been an entrepreneur, executive, and consultant in the nuclear medicine and nuclear energy industries since 2010. Kirk currently serves as fractional CEO and general counsel for Atom Mines, a medical isotope manufacturer specializing in the production of Ytterbium-176, an isotope needed to produce Lutetium-177 which is a key ingredient in cancer radiotherapies.

Kirk, based in Austin, Texas, has also served as fractional general counsel and President of the Pointsman Foundation, an Austin, Texas nonprofit organization advancing domestic production and use of stable isotopes and radioisotopes for medical treatments, diagnostics, and research.  Kirk has served as start-up counsel, IP counsel, and fractional general counsel to clients through his law firm, Dorius Law, since 2017, where he focuses on helping clients with patents, trademarks, copyrights and licensing of IP, and previously worked as a patent attorney with national firms and as a mechanical engineer with a missile defense contractor.  Kirk has advised clients acquired by IBM, Apple, Cirrus Logic, and Digital Domain.

Kirk has particular expertise and interest in isotope separation, molten salt nuclear reactor developments, and intellectual property law.  Kirk studied mechanical engineering at Utah State University and intellectual property law at the University of New Hampshire. He is the author of the very intriguing article, "AI Wrote My Patent Application in 30 Seconds and It Is Now Pending with the USPTO and Will Soon Be Licensed," posted on LinkedIn in February, 2023.

© 2026 Nucleation Capital | Terms & Policies

Nucleation-Logo